Definitive chemoradiotherapy for adenoid cystic carcinoma of the trachea: A case report

Lionel Eric Francis Edimo 1, *, Khadidjatou Badji 1, Awa Sadikh Badiane 1, Ndeye F.K BA 1, Mamadou Moustapha DIENG ² and Pape Macoumba GAYE 1

1 Department of Radiotherapy, Dalal Jamm Hospital, Dakar, Senegal.
2 Department of Radiotherapy, Joliot-Curie Institute of Aristide Dantec Hospital, Dakar, Senegal
 
Case Study
World Journal of Advanced Research and Reviews, 2023, 20(02), 1082–1086
Article DOI: 10.30574/wjarr.2023.20.2.2355
 
Publication history: 
Received on 25 September 2023; revised on 18 November 2023; accepted on 20 November 2023
 
Abstract: 
Adenoid cystic carcinoma is a malignant tumour rarely found in trachea, and even less so in our sub-region. In addition to a slow clinical course, this histology has a predilection for perineural invasion and a tendency for local and distant recurrence. Most patients present with dyspnea and symptoms often mimic those of asthma or chronic bronchitis. Although surgical resection is the mainstay of treatment, tumour size and location, comorbidities and patient reluctance may prevent surgery. Furthermore, the recognized chemoresistance of this histological type means that radiotherapy, whether definitive or adjuvant, plays a major role in its management. We report the case of a 30-year-old patient treated in our department with definitive chemoradiotherapy.
 
Keywords: 
Adenoid cystic carcinoma; Trachea; Radiotherapy; Senegal
 
Full text article in PDF: 
Share this